Buprenorphine transdermal skin patch and Glatiramer Subcutaneous
Determining the interaction of Buprenorphine transdermal skin patch and Glatiramer Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Glatopa
- Buprenorphine transdermal skin patch-Glatopa injection
- Buprenorphine transdermal skin patch-Glecaprevir and pibrentasvir
- Buprenorphine transdermal skin patch-Gleevec
- Buprenorphine transdermal skin patch-Glenmax PEB DM
- Buprenorphine transdermal skin patch-Glenmax PEB DM FORTE
- Glatiramer Subcutaneous-Buprenorphine, Buprenorphine Hydrochloride
- Glatiramer Subcutaneous-Buprenorphine/naloxone Oromucosal, Sublingual
- Glatiramer Subcutaneous-Buproban
- Glatiramer Subcutaneous-Bupropion
- Glatiramer Subcutaneous-Bupropion and naltrexone
- Glatiramer Subcutaneous-Bupropion Extended-Release Tablets